Clinical trial · Observational
Feasibility of Mutational Analysis of Non-Small Cell Lung Cancer (NSCLC) Using Low-volume Lung Aspirates
Feasibility of Gene Expression Profiling Using Low-volume Lung Aspirate
NCT01482572CI-TRIAL-00019873withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the feasibility of aspiration samples for mutational analysis in patients with a non-small cell lung cancer (NSCLC).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Gene profiling Success
- interventionNames
- Procedure: biopsy
Primary outcomes (1)
- measure
- Success rates for mutation analysis
- timeFrame
- one year
Secondary outcomes (1)
- measure
- Technical success rate of biopsy procedure
- timeFrame
- one year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * primary tumor or a metastatic lung lesion requested for mutational analysis Exclusion Criteria: * a) lesions located adjacent to the large central bronchi or vessels * b) peribronchovascular lesions with prominent internal CT air-bronchograms, which were considered difficult to be avoided by needle pass * c) lesions in patient with severe respiratory compromise
References
Publications (0)
Data not yet available
No reference posted for this study.